AWA
ARS Wealth Advisors Portfolio holdings
AUM
$556M
Turnover
17.12%
1-Year Est. Return
30.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+30.03%
3 Year Est. Return
+61.81%
5 Year Est. Return
+96.2%
10 Year Est. Return
–
AUM
$314M
AUM Growth
+$847K
(+0.27%)
Cap. Flow
-$12.3M
Cap. Flow
% of AUM
-3.92%
Top 10 Holdings %
Top 10 Hldgs %
65.2%
Holding
111
New
4
Increased
54
Reduced
37
Closed
2
Avg Time Held
3.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
|
+$2.66M |
| 2 |
iShares MSCI USA Equal Weighted ETF
EUSA
|
+$1.42M |
| 3 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$918K |
| 4 |
Johnson & Johnson
JNJ
|
+$506K |
| 5 |
Hershey
HSY
|
+$373K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Variable Rate Investment Grade ETF
VRIG
|
+$12.4M |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$3.5M |
| 3 |
iShares US Pharmaceuticals ETF
IHE
|
+$2.5M |
| 4 |
Invesco KBW Bank ETF
KBWB
|
+$644K |
| 5 |
Apple
AAPL
|
+$532K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.11% |
| 2 | Technology | 7.67% |
| 3 | Financials | 7.49% |
| 4 | Consumer Staples | 7.04% |
| 5 | Healthcare | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Eli Lilly
LLY
$1.08T
| $643K | 0.2% |
5,803
-78
| -1% | -$9.19K |
2014 Q2
20 quarters
|
|
52
Aflac
AFL
$59.3B
| $642K | 0.2% |
11,722
+3
| +0% | +$155 |
2015 Q1
17 quarters
|
|
53
Philip Morris
PM
$320B
| $588K | 0.19% |
7,490
-177
| -2% | -$14.6K |
2013 Q4
22 quarters
|
|
54
Abbott
ABT
$178B
| $587K | 0.19% |
6,979
+3,645
| +109% | +$287K |
2018 Q3
3 quarters
|
|
55
Novartis
NVS
$279B
| $585K | 0.19% |
6,410
-838
| -12% | -$70.9K |
2016 Q3
11 quarters
|
|
56
Union Pacific
UNP
$170B
| $578K | 0.18% |
3,420
-71
| -2% | -$12.2K |
2013 Q4
22 quarters
|
|
57
iShares Core S&P Total US Stock Market ETF
ITOT
$96.7B
| $576K | 0.18% |
8,652
+375
| +5% | +$24.6K |
2018 Q4
2 quarters
|
|
58
Thermo Fisher Scientific
TMO
$249B
| $559K | 0.18% |
1,902
-15
| -0.8% | -$4.13K |
2013 Q4
22 quarters
|
|
59
Caterpillar
CAT
$344B
| $552K | 0.18% |
4,050
+500
| +14% | +$66.1K |
2017 Q1
9 quarters
|
|
60
ConocoPhillips
COP
$171B
| $550K | 0.18% |
9,024
-1,025
| -10% | -$63.8K |
2016 Q2
12 quarters
|
|
61
Wells Fargo
WFC
$243B
| $548K | 0.17% |
11,580
-2,371
| -17% | -$111K |
2015 Q3
15 quarters
|
|
62
Bank of America
BAC
$359B
| $535K | 0.17% |
18,453
+845
| +5% | +$24.4K |
2016 Q4
10 quarters
|
|
63
Starbucks
SBUX
$106B
| $482K | 0.15% |
5,752
+292
| +5% | +$22.9K |
2016 Q3
11 quarters
|
|
64
3M
MMM
$84.8B
| $475K | 0.15% |
3,279
+151
| +5% | +$23.2K |
2014 Q2
20 quarters
|
|
65
NextEra Energy
NEE
$163B
| $473K | 0.15% |
9,244
+1,908
| +26% | +$93.9K |
2017 Q1
9 quarters
|
|
66
Welltower
WELL
$167B
| $449K | 0.14% |
5,510
-10
| -0.2% | -$786 |
2015 Q3
15 quarters
|
|
67
Salesforce
CRM
$194B
| $441K | 0.14% |
2,905
| – | – |
2016 Q3
11 quarters
|
|
68
CVS Health
CVS
$116B
| $439K | 0.14% |
8,061
+2
| +0% | +$108 |
2013 Q4
22 quarters
|
|
|
69
Hershey
HSY
$33B
| $394K | 0.13% |
+2,939
| New | +$373K |
2019 Q2
0 quarters
|
|
70
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
| $391K | 0.12% |
7,318
| – | – |
2013 Q4
22 quarters
|
|
71
AbbVie
ABBV
$501B
| $389K | 0.12% |
5,350
+1,751
| +49% | +$138K |
2017 Q3
7 quarters
|
|
72
J.M. Smucker
SJM
$13B
| $387K | 0.12% |
3,360
+175
| +5% | +$21.4K |
2014 Q2
20 quarters
|
|
|
73
Invesco KBW Bank ETF
KBWB
$6.11B
| $380K | 0.12% |
7,526
-12,815
| -63% | -$644K |
2018 Q2
4 quarters
|
|
74
CSX Corp
CSX
$89.4B
| $379K | 0.12% |
14,682
-495
| -3% | -$12.8K |
2017 Q1
9 quarters
|
|
75
Vanguard FTSE Developed Markets ETF
VEA
$227B
| $373K | 0.12% |
8,947
-111
| -1% | -$4.58K |
2017 Q4
6 quarters
|
|
Similar funds
HFA
PPSG
PMAS
APA
HH
SA
EMG
SCM
ARS Wealth Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ARS Wealth Advisors held 111 positions worth $314M, up 0.27% from $313M the previous quarter. Its ten largest holdings account for 65% of the portfolio.
ARS Wealth Advisors withdrew a net $12.3M in Q2 2019, closing 2 positions and reducing 37 holdings. Its most notable exit was Amgen, an estimated $222K position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 58% a quarter earlier, followed by Technology and Financials.
Against the trend, ARS Wealth Advisors opened a new position in Hershey worth $394K.
- ARS Wealth Advisors's largest Q2 2019 buy was Hershey: 2,939 shares worth $394K.
- ARS Wealth Advisors added most to State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF in Q2 2019, an estimated $2.66M increase.
- ARS Wealth Advisors's biggest Q2 2019 reduction was Invesco Variable Rate Investment Grade ETF, cutting an estimated $12.4M.
- ARS Wealth Advisors fully exited Amgen in Q2 2019, selling an estimated $222K.
- ARS Wealth Advisors's ten largest holdings make up 65% of its $314M portfolio in Q2 2019.
- ARS Wealth Advisors opened 4 new positions and closed 2 in Q2 2019.
- ARS Wealth Advisors's portfolio value rose 0.27% quarter-over-quarter to $314M.
Based on ARS Wealth Advisors's 13F filing for Q2 2019, filed 11 Jun 2021.